In other cases, the patient might have specific medical needs and health conditions that the commercially available Mounjaro cannot address
Other GLP-1R/GIPR co-agonists such as Cpd86 (Eli Lilly), ZP-DI-70 (Zealand) and NN9709/MAR709 (Novo Nordisk/Marcadia) have also been designed and tested in preclinical models of obesity and subsequently advanced to clinical trials (Table 1)
If several of your answers were no, you may discover that improving your nutrition, hydration, or daily habits gets things moving again without changing your medication
The medication is used for the treatment of type 2 diabetes, weight management, and cardiovascular risk reduction
The FDA approved Lillys Mounjaro for Type 2 diabetes in 2022 and Zepbound for obesity in 2023
Bacteriostatic Water (Recommended) Bacteriostatic water is sterile water with 0.9% benzyl alcohol added as a preservative